18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes.

Mahfouz, T; Miceli, M H; Saghafifar, F; Stroud, S; Jones-Jackson, L; Walker, R; Grazziutti, M L; Purnell, G; Fassas, A; Tricot, G; Barlogie, B; Anaissie, E

Mahfouz, T; Miceli, M H; Saghafifar, F; Stroud, S; Jones-Jackson, L; Walker, R; Grazziutti, M L; Purnell, G; Fassas, A; Tricot, G; Barlogie, B; Anaissie, E.

Affiliation

Mahfouz T; University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy, Little Rock, 72205, USA.

J Clin Oncol ; 23(31): 7857-63, 2005 Nov 01.

Article in En | MEDLINE | ID: mdl-16204017

Subject(s)

Fluorodeoxyglucose F18; Joint Diseases/diagnostic imaging; Multiple Myeloma/diagnostic imaging; Radiopharmaceuticals; Soft Tissue Infections/diagnostic imaging; Tomography, Emission-Computed; Adult; Aged; Anti-Bacterial Agents/therapeutic use; Female; Humans; Joint Diseases/microbiology; Male; Medical Records; Middle Aged; Multiple Myeloma/microbiology; Retrospective Studies; Soft Tissue Infections/microbiology; Time Factors

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Tomography, Emission-Computed / Soft Tissue Infections / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Joint Diseases / Multiple Myeloma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2005 Type: Article

Search on Google

XML

PubMed Links